In vitro testing with high performance & broad applicability
SenzaGen is an innovative biotech company that develops and sells in vitro test methods for safety testing of various toxicological endpoints across various industries. The assays replace animal methods with genomics combined with machine learning, providing high informational content and a holistic view of the immunological responses, leading to high predictive accuracy. The current portfolio includes the GARD™ (Genomic Allergen Rapid Detection) assays for skin and respiratory sensitization.